author_facet Schroder, W.
Witteveen, E.
Abadie, S.
Campone, M.
Viens, P.
Jalava, T.
Masson, E.
Chlistalla, A.
Du Bois, A.
Schroder, W.
Witteveen, E.
Abadie, S.
Campone, M.
Viens, P.
Jalava, T.
Masson, E.
Chlistalla, A.
Du Bois, A.
author Schroder, W.
Witteveen, E.
Abadie, S.
Campone, M.
Viens, P.
Jalava, T.
Masson, E.
Chlistalla, A.
Du Bois, A.
spellingShingle Schroder, W.
Witteveen, E.
Abadie, S.
Campone, M.
Viens, P.
Jalava, T.
Masson, E.
Chlistalla, A.
Du Bois, A.
Journal of Clinical Oncology
A phase IB, open label, safety and pharmacokinetic (PK) study of escalating doses of PTK787/ZK 222584 in combination with paclitaxel and carboplatin in patients (PTs) with stage IIC to IV epithelial ovarian cancer
Cancer Research
Oncology
author_sort schroder, w.
spelling Schroder, W. Witteveen, E. Abadie, S. Campone, M. Viens, P. Jalava, T. Masson, E. Chlistalla, A. Du Bois, A. 0732-183X 1527-7755 American Society of Clinical Oncology (ASCO) Cancer Research Oncology http://dx.doi.org/10.1200/jco.2005.23.16_suppl.5042 A phase IB, open label, safety and pharmacokinetic (PK) study of escalating doses of PTK787/ZK 222584 in combination with paclitaxel and carboplatin in patients (PTs) with stage IIC to IV epithelial ovarian cancer Journal of Clinical Oncology
doi_str_mv 10.1200/jco.2005.23.16_suppl.5042
facet_avail Online
Free
finc_class_facet Medizin
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTIwMC9qY28uMjAwNS4yMy4xNl9zdXBwbC41MDQy
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTIwMC9qY28uMjAwNS4yMy4xNl9zdXBwbC41MDQy
institution DE-Gla1
DE-Zi4
DE-15
DE-Pl11
DE-Rs1
DE-105
DE-14
DE-Ch1
DE-L229
DE-D275
DE-Bn3
DE-Brt1
DE-Zwi2
DE-D161
imprint American Society of Clinical Oncology (ASCO), 2005
imprint_str_mv American Society of Clinical Oncology (ASCO), 2005
issn 0732-183X
1527-7755
issn_str_mv 0732-183X
1527-7755
language English
mega_collection American Society of Clinical Oncology (ASCO) (CrossRef)
match_str schroder2005aphaseibopenlabelsafetyandpharmacokineticpkstudyofescalatingdosesofptk787zk222584incombinationwithpaclitaxelandcarboplatininpatientsptswithstageiictoivepithelialovariancancer
publishDateSort 2005
publisher American Society of Clinical Oncology (ASCO)
recordtype ai
record_format ai
series Journal of Clinical Oncology
source_id 49
title A phase IB, open label, safety and pharmacokinetic (PK) study of escalating doses of PTK787/ZK 222584 in combination with paclitaxel and carboplatin in patients (PTs) with stage IIC to IV epithelial ovarian cancer
title_unstemmed A phase IB, open label, safety and pharmacokinetic (PK) study of escalating doses of PTK787/ZK 222584 in combination with paclitaxel and carboplatin in patients (PTs) with stage IIC to IV epithelial ovarian cancer
title_full A phase IB, open label, safety and pharmacokinetic (PK) study of escalating doses of PTK787/ZK 222584 in combination with paclitaxel and carboplatin in patients (PTs) with stage IIC to IV epithelial ovarian cancer
title_fullStr A phase IB, open label, safety and pharmacokinetic (PK) study of escalating doses of PTK787/ZK 222584 in combination with paclitaxel and carboplatin in patients (PTs) with stage IIC to IV epithelial ovarian cancer
title_full_unstemmed A phase IB, open label, safety and pharmacokinetic (PK) study of escalating doses of PTK787/ZK 222584 in combination with paclitaxel and carboplatin in patients (PTs) with stage IIC to IV epithelial ovarian cancer
title_short A phase IB, open label, safety and pharmacokinetic (PK) study of escalating doses of PTK787/ZK 222584 in combination with paclitaxel and carboplatin in patients (PTs) with stage IIC to IV epithelial ovarian cancer
title_sort a phase ib, open label, safety and pharmacokinetic (pk) study of escalating doses of ptk787/zk 222584 in combination with paclitaxel and carboplatin in patients (pts) with stage iic to iv epithelial ovarian cancer
topic Cancer Research
Oncology
url http://dx.doi.org/10.1200/jco.2005.23.16_suppl.5042
publishDate 2005
physical 5042-5042
description
container_issue 16_suppl
container_start_page 5042
container_title Journal of Clinical Oncology
container_volume 23
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792323359906725896
geogr_code not assigned
last_indexed 2024-03-01T11:32:35.025Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=A+phase+IB%2C+open+label%2C+safety+and+pharmacokinetic+%28PK%29+study+of+escalating+doses+of+PTK787%2FZK+222584+in+combination+with+paclitaxel+and+carboplatin+in+patients+%28PTs%29+with+stage+IIC+to+IV+epithelial+ovarian+cancer&rft.date=2005-06-01&genre=article&issn=1527-7755&volume=23&issue=16_suppl&spage=5042&epage=5042&pages=5042-5042&jtitle=Journal+of+Clinical+Oncology&atitle=A+phase+IB%2C+open+label%2C+safety+and+pharmacokinetic+%28PK%29+study+of+escalating+doses+of+PTK787%2FZK+222584+in+combination+with+paclitaxel+and+carboplatin+in+patients+%28PTs%29+with+stage+IIC+to+IV+epithelial+ovarian+cancer&aulast=Du+Bois&aufirst=A.&rft_id=info%3Adoi%2F10.1200%2Fjco.2005.23.16_suppl.5042&rft.language%5B0%5D=eng
SOLR
_version_ 1792323359906725896
author Schroder, W., Witteveen, E., Abadie, S., Campone, M., Viens, P., Jalava, T., Masson, E., Chlistalla, A., Du Bois, A.
author_facet Schroder, W., Witteveen, E., Abadie, S., Campone, M., Viens, P., Jalava, T., Masson, E., Chlistalla, A., Du Bois, A., Schroder, W., Witteveen, E., Abadie, S., Campone, M., Viens, P., Jalava, T., Masson, E., Chlistalla, A., Du Bois, A.
author_sort schroder, w.
container_issue 16_suppl
container_start_page 5042
container_title Journal of Clinical Oncology
container_volume 23
description
doi_str_mv 10.1200/jco.2005.23.16_suppl.5042
facet_avail Online, Free
finc_class_facet Medizin
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTIwMC9qY28uMjAwNS4yMy4xNl9zdXBwbC41MDQy
imprint American Society of Clinical Oncology (ASCO), 2005
imprint_str_mv American Society of Clinical Oncology (ASCO), 2005
institution DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161
issn 0732-183X, 1527-7755
issn_str_mv 0732-183X, 1527-7755
language English
last_indexed 2024-03-01T11:32:35.025Z
match_str schroder2005aphaseibopenlabelsafetyandpharmacokineticpkstudyofescalatingdosesofptk787zk222584incombinationwithpaclitaxelandcarboplatininpatientsptswithstageiictoivepithelialovariancancer
mega_collection American Society of Clinical Oncology (ASCO) (CrossRef)
physical 5042-5042
publishDate 2005
publishDateSort 2005
publisher American Society of Clinical Oncology (ASCO)
record_format ai
recordtype ai
series Journal of Clinical Oncology
source_id 49
spelling Schroder, W. Witteveen, E. Abadie, S. Campone, M. Viens, P. Jalava, T. Masson, E. Chlistalla, A. Du Bois, A. 0732-183X 1527-7755 American Society of Clinical Oncology (ASCO) Cancer Research Oncology http://dx.doi.org/10.1200/jco.2005.23.16_suppl.5042 A phase IB, open label, safety and pharmacokinetic (PK) study of escalating doses of PTK787/ZK 222584 in combination with paclitaxel and carboplatin in patients (PTs) with stage IIC to IV epithelial ovarian cancer Journal of Clinical Oncology
spellingShingle Schroder, W., Witteveen, E., Abadie, S., Campone, M., Viens, P., Jalava, T., Masson, E., Chlistalla, A., Du Bois, A., Journal of Clinical Oncology, A phase IB, open label, safety and pharmacokinetic (PK) study of escalating doses of PTK787/ZK 222584 in combination with paclitaxel and carboplatin in patients (PTs) with stage IIC to IV epithelial ovarian cancer, Cancer Research, Oncology
title A phase IB, open label, safety and pharmacokinetic (PK) study of escalating doses of PTK787/ZK 222584 in combination with paclitaxel and carboplatin in patients (PTs) with stage IIC to IV epithelial ovarian cancer
title_full A phase IB, open label, safety and pharmacokinetic (PK) study of escalating doses of PTK787/ZK 222584 in combination with paclitaxel and carboplatin in patients (PTs) with stage IIC to IV epithelial ovarian cancer
title_fullStr A phase IB, open label, safety and pharmacokinetic (PK) study of escalating doses of PTK787/ZK 222584 in combination with paclitaxel and carboplatin in patients (PTs) with stage IIC to IV epithelial ovarian cancer
title_full_unstemmed A phase IB, open label, safety and pharmacokinetic (PK) study of escalating doses of PTK787/ZK 222584 in combination with paclitaxel and carboplatin in patients (PTs) with stage IIC to IV epithelial ovarian cancer
title_short A phase IB, open label, safety and pharmacokinetic (PK) study of escalating doses of PTK787/ZK 222584 in combination with paclitaxel and carboplatin in patients (PTs) with stage IIC to IV epithelial ovarian cancer
title_sort a phase ib, open label, safety and pharmacokinetic (pk) study of escalating doses of ptk787/zk 222584 in combination with paclitaxel and carboplatin in patients (pts) with stage iic to iv epithelial ovarian cancer
title_unstemmed A phase IB, open label, safety and pharmacokinetic (PK) study of escalating doses of PTK787/ZK 222584 in combination with paclitaxel and carboplatin in patients (PTs) with stage IIC to IV epithelial ovarian cancer
topic Cancer Research, Oncology
url http://dx.doi.org/10.1200/jco.2005.23.16_suppl.5042